Actinobacillus actinomycetemcomitans produces a leukotoxin that kills human polymorphonuclear cells (PMNs) and monocytes but not lymphocytes. In this study, we examined A. actinomycetemcomitans leukotoxin for its ability to alter human peripheral blood lymphocyte (HPBL) responsiveness. After a 90-min exposure to the leukotoxin, all monocytes were killed and HPBL responsiveness to mitogens and antigens was significantly inhibited. The ability of the leukotoxin to inhibit HPBL responses was not surprising, since monocytes and macrophages are required for many lymphocyte functions. However, we were unable to totally restore HPBL responsiveness when adherent autologous monocytes were added back to cultures of leukotoxin-treated lymphocytes. These studies demonstrate that A. actinomycetemcomitans leukotoxin may also exert nonlethal effects directly on lymphocytes. Furthermore, impaired lymphocyte function did not appear to be the result of indirect effects of products released by dying monocytes. Although it is not clear how A.
Actinobacillus actinomycetemcomitans, a gram-negative, capnophilic bacterium, is a suspected etiologic agent in certain forms of periodontal disease and has been isolated in relatively high concentrations from the pathological pockets ofjuvenile periodontitis patients (for a review, see reference 46) . The organism also has been identified in the blood samples of patients with bacterial endocarditis, meningitis, and abscesses of the jaw and face (4, 9, 10, 19, 40) . Although the mechanism by which A. actinomycetemcomitans might contribute to the development of periodontal disease is not clear, it is known that this organism produces several biologically active mediators, including an immunosuppressive factor capable of activating human T suppressor cells (28, 29) , an endotoxin capable of promoting bone resorption (13) , a polyclonal B-cell activator (44) , a factor(s) capable of inhibiting fibroblast, endothelial, and epithelial cell proliferation (12, 26, 33) , and a leukotoxin capable of killing human polymorphonuclear cells (PMNs) and monocytes (1, 2, 16, 32) . The leukotoxin may be particularly important because of the critical role that monocytes and macrophages play in host defense in general and in the immune response in particular.
Although the nature and contribution of the immune system to the pathogenesis of periodontal disease are poorly understood, there is a vast literature supporting the view that the immune system plays a beneficial role in protecting and limiting bacterial infection in the gingival region (3, 7, 20, 21) . Furthermore, there is evidence that immune dysfunction, which may be characterized as a deficiency or defect in either cellular or humoral immunity, may contribute to susceptibility to, and progression of, periodontal disease (15, 23, 31, 34, 35) . It is in this context that we initiated the present study. We have examined A. actinomycetemcomi-* Corresponding author. tans leukotoxin (LTX) for its ability to alter human lymphocyte function and found that it inhibits lymphoid responsiveness to both mitogens and antigens. Although part of this inhibitory effect can be attributed to the depletion of monocytes, our study indicates that the LTX also has direct, nonlethal effects on lymphocytes as well.
MATERIALS AND METHODS
Isolation and preparation of HPBLs. Human peripheral blood lymphocytes (HPBLs) were prepared as described previously (25). Briefly, HPBLs were prepared from 100 to 200 ml of heparinized venous blood of healthy donors. The blood was first centrifuged at 300 x g for 15 min at 5°C; the plasma was removed, and the cells were brought back to the original volume with Hanks balanced salt solution (HBSS). Erythrocytes were eliminated by sedimentation through 1.25% dextran (Dextran T500; Pharmacia Fine Chemicals, Piscataway, N.J.). HPBLs were then isolated by buoyant density centrifugation on Ficoll-Hypaque (LSM; Litton Bionetics, Kensington, Md.) by the method of Boyum (6) Monocyte purification. Monocyte-enriched cell populations were prepared as previously described (27) . Briefly, HPBLs were diluted to 2 x 106 cells per ml in RPMI 1640 containing 10% FBS. The cell suspension (12 to 15 ml) was incubated in 75-cm2 flasks (Corning Plastics, Corning, N.Y.) that had been preincubated at 37°C with 10 ml of RPMI 1640 containing 10% FBS for at least 30 min. After 1 h of incubation at 37°C, the nonadherent cells were removed and the flasks were washed twice with warm medium. Cells still remaining attached to the plastic surface were then removed by adding 10 ml of cold phosphate-buffered saline containing 10% FBS and gently scraping the surface with a rubber policeman. The adherent cells were washed two times and suspended to 2 x 105 cells in culture medium; these cells were found to routinely contain >90% monocytes when assessed by both morphologic appearance and nonspecific esterase staining.
RESULTS
The ability of A. actinomycetemcomitans to kill human monocytes and PMNs has been described by Taichman and colleagues (1, 2, 16, 32) ; cytotoxicity can be demonstrated by release of lactate dehydrogenase or 51Cr, as well as by a decrease in the ability of cells to exclude trypan blue. Killing is time, dose, and temperature dependent. We first wanted to determine if all monocytes present in our HPBL preparations were killed by the LTX and verify that lymphocyte viability remained unaltered. We first determined the percentage of monocytes present in the HPBL population by both morphologic appearance and nonspecific esterase staining; we routinely observed the presence of 15 to 20% monocytes (Table 1) . After the cells were exposed to LTX, we examined the cells for viability by trypan blue exclusion. Cells exposed to LTX contained 12.5 to 15% dead cells as assessed by trypan blue exclusion; this represents 80 to 85% of the total monocytes present. We suspect that the actual percentage of dead cells was slightly higher, however; because of the long exposure period (90 min), some dead cells most likely distintegrated before microscopic evaluation (Norton Taichman, personal communication). Furthermore, no monocytes could be identified by morphology or nonspecific esterase staining after treatment with LTX. No change in cell viability was observed in cultures exposed to medium (control), to LTX previously treated with a neutralizing monoclonal antibody, or to LTX previously heated (56°C). As reported by Taichman and co-workers (32, 37), lymphocyte viability was not altered after a 90-min exposure to the toxin. Effect of LTX on lymphocyte function. The dependency on monocytes and macrophages for full expression of human lymphocyte responsiveness is well documented (36, 39) . Therefore, to further verify LTX depletion of monocytes, we examined the effects of toxin treatment on several aspects of lymphocyte responsiveness. The proliferative response to both B-and T-cell mitogens was reduced in cells exposed to LTX compared with control cells; we observed inhibition of 75, 30, 65, and 50% for ConA-, PHA-, PWM-, and formalinized S. aureus-activated cells, respectively (Fig. 1) . We also observed similar effects on RNA and protein synthesis (data not shown). We have previously shown that in addition to LTX, A. actinomycetemcomitans produces an immunosuppressive factor that acts via activation of T suppressor cells. It was, therefore, important to demonstrate that the observed inhibition of HPBL proliferation was in fact due to LTX, rather than the immunosuppressive factor. This was unlikely, however, since we used pure LTX we also used a monoclonal antibody to LTX which has been shown to neutralize toxic activity but not the A. actinomycetemcomitans-immunosuppressive factor. This antibody protected monocytes from the lethal effects of LTX and lymphocytes from the inhibitory effects of the toxin ( Fig. 1 ; Table 1 ). We also examined lymphocytes for responses to antigens streptokinase-streptodornase and tetanus toxoid after exposure to LTX. Proliferative responses to both antigens were significantly suppressed after treatment with the LTX (Fig. 1) . Finally, we examined lymphocytes for their ability to synthesize and secrete immunoglobulin. Exposure to LTX resulted in 95% inhibition of IgG and 80% inhibition of IgM production (Fig. 2) .
Effect of readdition of monocytes on LTX-mediated lymphocyte suppression. Thus far, we have demonstrated that LTX is capable of inhibiting a wide range of lymphocyte responses. These findings were not surprising since we also demonstrated that the LTX killed virtually all monocytes present in our cell population. In vitro and in vivo lymphocyte responses to both mitogens and antigens are complex processes involving the interaction of several cells, including subsets of lymphocytes (T helper, T suppressor, B, etc.) and monocytes (or macrophages) (18, 36, 39) . To verify that the immunosuppressive effects of the LTX were in fact due to monocyte depletion, we performed experiments in which purified monocytes were added back to LTX-treated HPBL cultures and the cells were then tested for mitogen respon- (Fig. 3) . As already documented, HPBLs treated with LTX exhibited significant impairment in their ability to proliferate in response to ConA, PHA, and PWM. However, when monocytes were added back at concentrations of either 10 or 20% of the total culture, we observed only slight recovery of ConA and PWM responsiveness. Similar effects were observed with PWM-induced immunoglobulin production as well (data not shown). On the other hand, PHA responsiveness was totally restored. These results suggest that the depletion of monocytes alone cannot account for all the suppression observed after exposure to LTX. Another possible explanation is that lymphocytes are indirectly damaged by LTX through the killing of monocytes. We addressed this possibility by the experiments shown in Fig. 4 . Here, we compared the effects of LTX and a lysosomotropic agent (36) , leucine methyl ester (LME), on lymphocyte responsiveness. Exposure of HPBLs to either LTX or LME resulted in depletion of all monocytes and depression of lymphocyte responsiveness. The proliferative response of LME-treated cells was totally restored by the addition of monocytes; in contrast, the proliferative response of LTXtreated cells remained impaired. These results suggest that the LTX may have direct, but nonlethal, effects on lymphocytes themselves.
DISCUSSION
Microbial virulence may be the consequence of their ability to resist, escape, or subvert host defense mechanisms. In regards to the last, several microorganisms are capable of suppressing the immune response through various products, including toxins, enzymes, cell wall components, and metabolites (for a review, see reference 22). Furthermore, several suspected periodontal pathogens are also capable of suppressing lymphocyte responses in vitro; these include Treponema denticola (27) produces several factors that can subvert host defense mechanisms. For example, we have previously demonstrated that A. actinomycetemcomitans produces a factor capable of activating T suppressor cells, which in turn down-regulates lymphocyte responsiveness (29) . Taichman and colleagues (1, 2, 16, 32, 37) have also demonstrated that many strains of A. actinomycetemcomitans produce a toxin capable of killing human PMNs and monocytes. These potential virulence factors have been shown to be separate entities, based on the following. (i) The monoclonal antibodies made against one factor are unable to modify the activity of the other factor. (ii) Both factors can be chromatographically separated. (iii) The immunosuppressive factor is found in all strains of A. actinomycetemcomitans, whereas LTX is only found in some strains. In this report, we have demonstrated that the LTX is capable not only of killing human monocytes but also of impairing lymphocyte responsiveness. Although part of this impairment is the result of monocyte depletion, the LTX also appears to have nonlethal effects on lymphocytes as well. LTX inhibition involves both B and T cells and is reflected in altered DNA, RNA, and protein synthesis, as well as immunoglobulin production. Lymphocyte viability was not altered. Only partial responsiveness was restored when autologous monocytes were added to LTX-treated cells. Furthermore, effects on lymphocytes do not appear to be the result of products released from dying monocytes and, thereby, influencing innocent bystander cells. This was demonstrated by comparing the effects of LTX and the lysosomotropic agent, LME; this agent has previously been shown to selectively kill monocytes, rendering lymphocytes unresponsive to B-and T-cell stimulants (36) . Although both agents killed virtually all monocytes present in our HPBL populations and decreased lymphocyte proliferation, the responsiveness of the LME-treated cells was fully restored by the addition of monocytes, whereas cells exposed to LTX remained impaired. It is interesting that PHA responses were minimally affected by LTX treatment and were fully restored by the addition of monocytes. Although PHA and ConA may stimulate slightly different human T-cell subpopulations, the responses to both mitogens have been shown to be dependent upon monocytes (36) . These findings, therefore, suggest VOL. 56, 1987 that LTX does not directly affect all lymphocytes but rather a subset of these cells. The latter finding also indicates that these observations are not due to the carry-over of LTX into the cultures, resulting in killing of the replenished monocytes. At this time, it is premature to speculate on the mode of action by which LTX alters lymphocyte responsiveness.
Microbial products represent an important source of immunoregulatory agents, some of which may affect the immune response via several different mechanisms that interfere with either the induction or expression of immunity. For example, streptococcal products inhibit bone marrow stem cell maturation (10), whereas cholera toxin interacts with mature cells (42) . The latter results in suppression of T-cell effector populations in vitro and in vivo and is associated with the activation of adenylate cyclase and intracellular accumulation of cyclic AMP (30) . On the other hand, products of Corynebacterium parvum and T. denticola affect macrophages, provoking the release of mediators capable of inhibiting lymphocyte function (17, 27) . T regulatory cells are also a potent target for microbial modulation of the immune response. A. actinomycetemcomitans has been shown to selectively, but nonspecifically, activate human T suppressor cells (28, 29) , whereas human immunodeficiency virus infects and destroys T helper cells (45) . Other bacterial products have been implicated in impairing macrophage function and blocking or preventing receptor expression (43) .
In summary, recent studies suggest a strong association between A. actinomycetemcomitans infection and the etiology ofjuvenile periodontitis (46) . Although the immunologic mechanism(s) involved in periodontal disease is not clearly defined, there is substantial evidence that impaired host defense mechanisms may contribute to the disease process. A. actinomycetemcomitans, in particular, may be able to upset antibacterial defense mechanisms in the gingival crevice. Several in vitro studies, including the present investigation, indicate that this organism can kill human peripheral blood and gingival crevice PMNs and monocytes, as well as adversely affect immune functions of human lymphocytes. Hence, bacterium-derived immunosuppressive and leukotoxic factors may contribute to the pathogenesis of periodontal disease. Such factors could lead to a state of hyporesponsiveness that favors colonization by the initiating organism or by other opportunistic organisms.
